Medical Discovery NewsBridging the World of Medical Discovery and You

Recent Episodes

Risk Free Test for Downs


Every healthy baby has twenty-three pairs of chromosomes in each cell. Just one less or one more and the fetus ends up with a genetic defect. Children with Downs Syndrome have an extra copy or trisomy of chromosome twenty-one. Today most expectant moms are offered genetic testing, with some screening for Down's.

Several tests can indicate a problem with the baby, but to be certain, doctors must perform invasive tests which carry the risk of miscarriage. It requires the insertion of a needle into the uterus to extract fluid surrounding the fetus for testing.

Now a new method undergoing trials is not only effective but risk-free since all it needs is the mother's blood. It analyzes fragments of fetal DNA floating in her blood. These DNA fragments, free of a cell, can be isolated from the plasma portion of the mother's blood. The test involves sequencing millions of DNA fragments to detect extra copies and it only takes a few days.

When researchers screened about a thousand expectant moms at ten weeks, there were fewer false positives compared to other noninvasive tests such as ultrasound and a hormone-based blood test. While the test result is not a certainty as you would expect with an amniocentesis, in trials it was ninety percent accurate in women who are more likely to have a downs baby.

In addition to Downs Syndrome, the test can also detect other similar genetic abnormalities such as Edwards syndrome involving trisomy of chromosome eighteen and Patau syndrome which is caused by trisomy of chromosome thirteen. Having this additional noninvasive test available to all expectant moms would offer them greater peace of mind through their pregnancy.

More Information

Down Syndrome
Comprehensive information on Down Syndrome from MedLine Plus, a service of the U.S. National Library of Medicine, National Institutes of Health

Down's pregnancy blood test on trial
"A simple blood test during pregnancy which can detect Down's syndrome in the developing foetus is to be trialled by the NHS."

Non-invasive first trimester blood test reliably detects Down's syndrome and other genetic fetal abnormalities
"New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. The results suggest that the test is superior to currently available screening strategies and could reshape standards in prenatal testing."


Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.

Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.

No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.

Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.


Alternatively, you can copy and paste the following web address (URL) into iTunes as a new subscription:

You can also search and subscribe to "Medical Discovery News" in the podcast section of iTunes.

See all podcasts and radio stations

The web site and Medical Discovery News radio program (Program) are made possible by The University of Texas Medical Branch at Galveston (UTMB)as a community service and are intended to advance UTMB's mission of providing scholarly teaching, innovative scientific investigation, and state-of-the-art patient care in a learning environment to better the health of society and its commitment to the discovery of new innovative biomedical and health services knowledge leading to increasingly effective and accessible health care for the citizens of Texas.

All information provided on the web site and in the Program is for informational purposes only and is not intended for use as diagnosis or treatment of a health problem or as a substitute for consulting a licensed medical professional. Any information obtained by participating as a web site visitor or program listener is not intended to and should not be considered to constitute medical advice.

Thoughts and opinions expressed on the Program or on the website are those of the authors or guests and do not necessarily reflect the opinions of UTMB. The provision of links to other websites is not to be construed as written or implied sponsorship or endorsement of such websites by UTMB.

Please contact Dr. David Niesel or Dr. Norbert Herzog via email with any concerns, suggestions or comments.

All rights are reserved to information provided on the website or other information sources. No part of these programs can be reproduced stored in a retrieval system or transcribed in any form or by any means for personal or financial gained without the express written permission of Drs. Niesel and Dr. Herzog.